HOME ONGOING PHASE IV RESEARCH Extended-release calcifediol (ERC) non-interventional study (NIS) on effectiveness in ND-CKD SHPT patients Nephrology and Rare Diseases CKD-MBD and SHPT Go to Clinicaltrials.gov Study summary Study type: Observational Study identification number: NCT05460234 Recruitment status: Recruiting Estimated enrollment: Up to 500 participants Actual study start date: 05 October 2022 Estimated study completion date: 01 December 2025 Contact details medinfo@viforpharma.com